Vical (VICL) researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. This stock closed up 2.2% to $1.29 in Thursday's trading session.
Thursday's Range: $1.27-$1.30
52-Week Range: $1.17-$4.51
Thursday's Volume: 774,000
Three-Month Average Volume: 2.14 million
From a technical perspective, VICL rose modestly higher here right above some near-term support at $1.25 with lighter-than-average volume. This stock has been trending sideways inside of a consolidation pattern for the last two months and change, with shares moving between $1.17 on the downside and $1.64 on the upside. This sideways trend is coming after shares of VICL gapped down sharply in August from $3.75 to $1.37 with heavy downside volume. Shares of VICL are now starting to trend within range of triggering a big breakout trade above the upper-end of its consolidating chart pattern. That trade will hit if VICL manages to take out its 50-day at $1.40, and then once it clears more key resistance levels at $1.44 to $1.64 with high volume.
....well we have the volume at 3.9M..we took out 1.44 and 1.53 and we are working on 1.64!